NEW YORK (Reuters) – Novartis AG (NOVN.S) agreed to pay $678 million to settle a civil fraud lawsuit brought by the U.S. government accusing the Swiss drugmaker of paying millions of dollars in kickbacks to doctors to induce them to prescribe its cardiovascular and diabetes drugs.

The U.S. Department of Justice announced the settlement late on Wednesday to resolve charges that Novartis violated the federal False Claims Act and an anti-kickback statute.

Novartis was accused of organizing tens of thousands of sham educational events where it provided doctors with exorbitant speaker fees, lavish dinners and expensive alcohol to induce more prescriptions.

Acting U.S. Attorney Audrey Strauss in Manhattan called the incentives “nothing more than bribes,” and said federal healthcare programs paid hundreds of millions of dollars in reimbursements for the tainted prescriptions.

“Giving these cash payments and other lavish goodies interferes with the duty of doctors to choose the best treatment for their patients and increases drug costs for everyone,” Strauss said in a statement.

Novartis admitted and accepted responsibility for many of the allegations and agreed to scale back its speaker programs.

The payout includes $591.4 million to the U.S. government as damages under the False Claims Act, a $38.4 million forfeiture for violating the anti-kickback statute, and $48.2 million to various U.S. states, the Justice Department said.

Reporting by Jonathan Stempel in New York; Editing by Sandra Maler and Leslie Adler

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Valentine’s Day sales set to rise in Germany

“All you need is love,” they say, but the famous American cartoonist Charles M. Schulz once added that “a little chocolate now and then doesn’t hurt.” It’s unlikely that the creator of the comic strip characters Charlie Brown and Snoopy had anything…

Coronavirus infects more than 100,000 worldwide, wreaking financial havoc

LONDON/LOS ANGELES (Reuters) – The number of people infected with coronavirus surpassed 100,000 across the world on Friday as the outbreak reached more countries and intensified economic damage, with business districts beginning to empty and stock markets tumbling. An increasing…

Wall Street set to open higher on hopes of stimulus, rebound

(Reuters) – Futures tracking the S&P 500 and the Dow Jones indexes edged higher on Monday following a selloff on Wall Street last week as investors weighed hopes of more stimulus and improving data against a resurgence in global coronavirus…

3rd CIIE starts 200-day countdown

Preparations for the third China International Import Expo (CIIE) are gaining momentum as the expo started its 200-day countdown on Saturday with the release of a promotional video. While addressing the ceremony, Sun Chenghai, deputy director of the CIIE Bureau,…